Simon Amies

• Indian Energy Limited, a wind farm operator in India, in connection with its recommended takeover by Infrastructure India plc.
• Galapagos NV on its recommended takeover of BioFocus plc.
• Baltic Oil Terminals PLC on its acquisitions of the Baltic Top Terminal business and Petroval Bunker International.
• Minster Pharmaceuticals PLC, an AIM-listed drug development company, on its recommended takeover by Proximagen Neuroscience PLC.
• MPS Global, a U.S.-based provider of high-tech engineering, design and IT talent, on its acquisition of UK-based Talascend Group.

Equity Capital Markets

• Sensyne Health plc on its formal sale process and strategic review culminating in a £26.35 million convertible note financing and de-listing from the AIM market.
• Arecor Therapeutics plc on its acquisition of Tetris Pharma Ltd and associated £6 million placing on the AIM market.
• Zeus Capital as sole bookrunner and nominated adviser to Devolver Digital, Inc. on its AIM IPO, raising $261 million through a UK placing and Rule 144A private placement in the United States, achieving a market capitalisation of $950 million which makes it the second largest IPO on AIM by market capitalisation in the past five years and the largest ever US-operating company by market capitalisation to be admitted to the London Stock Exchange across all markets.
• Arecor Therapeutics plc on its AIM IPO and £20 million placing.
• NCC Group PLC on its £72.6 million placing in connection with its $220 million acquisition of the Intellectual Property Management business of Iron Mountain Inc.
• Sensyne Health PLC on its £25 million placing, subscription and open offer.
• Horizon Discovery Group plc on a £6.9 million placing.
• Pharming NV on:
  • its offering of €125 million of senior unsecured convertible bonds;
  • its €104 million complex financing combination of redeemable convertible bonds, amortizable convertible bonds, and a rights issue with rump offer
• Safe Harbour Holdings PLC, a company established with the objective of creating a global leader in the B2B distribution and/or business services sphere, on its AIM IPO and £22.7 million placing
• Wilmcote Holdings PLC, a company established with the objective of acquiring and developing businesses in the downstream and specialty chemicals sector, on its AIM IPO and £15 million placing
• Allergy Therapeutics plc, the AIM-listed specialty pharmaceutical company, on:
  • an £11.5 million placing of ordinary shares;
  • the acquisition of Alerpharma, S.A. a Spanish-based allergy immunotherapy company; and
  • a £20 million placing of ordinary shares.
• Consort Medical plc on its £98.9 million rights issue in connection with the £230 million acquisition of Aesica Holdco Limited.
• Cenkos Securities plc as sole co-ordinator and bookrunner in relation to the AA’s £1.38 billion IPO on the London Main Market.
• Piper Jaffray Ltd., as sole financial advisor, sponsor, underwriter and broker to Vernalis plc on two placings and open offers raising in aggregate over £50 million.
• Indian Energy Limited, a wind farm operator in India, in connection with its IPO on AIM.
• Cenkos Securities, as nomad and broker to the £115 million placing by AIM-listed Tanfield Group plc to finance the acquisition of US-based Snorkel Holdings LLC.
• Baltic Oil Terminals PLC on its £60 million IPO.
• Northwest Biotherapeutics, Inc., an OTC Bulletin Board quoted US biotechnology company, on its admission to AIM and £15 million placing.
• Collins Stewart as nominated adviser and broker in connection with the AIM IPO of HipCricket, Inc.
• Galapagos NV on its admission to AIM and listings on Euronext Amsterdam and Euronext Brussels in connection with the recommended takeover of BioFocus plc.

Venture and Growth Capital

• BenevolentAI, a global leader in the creation and application of AI and machine learning to transform the way medicines are discovered and developed, on several investment rounds, including:
  • $90 million equity investment from Temasek, a Singapore-headquartered investment company; and
  • £80 million equity investment round by new and existing investors.
• Salesforce Ventures on:
  • its Series B and Series C investments in AI identity verification company Onfido;
  • its Series A investment in Hopin; and
  • its Series A investment in Crehana Education.
• Marubeni Corporation as lead investor in the $26 million Series B financing of Azuri Technologies Limited.
• Tencent Holdings Limited on its:
  • $20 million Series A financing in UK blockchain business Everledger; and
  • investment in Oxford Sciences Innovation plc.
• B.E.S.T. Funds in its equity investment in and subsequent exit from UK telematics company TrakGlobal Group.
• Drayson Technologies, in collaboration with Imperial Innovations plc, in the spin-out of wireless power technology from Imperial College.